Form D · Other Health Care
Kanvas Biosciences, Inc.
Monmouth Junction, NJ · CIK 0001980849
Offering snapshot reported Mar 18, 2024 · SEC filing
- Reported sold
- $3.91M Offering amount: $10M
- Investors reported
- 54 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 4, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 18, 2024 | Initial | $3,914,994 | No comparison | 54 | SEC filing |
| Jun 13, 2023 | Initial | $11,775,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-507864
The amounts listed do not include the issuance of up to an aggregate of 25,563,210 shares as a result of the conversion of convertible notes and SAFEs.
Source: Form D, filed Mar 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matthew Cheng | Director, Executive |
| Iwijn De Vlaminck | Director, Executive |
| Jason Pontin | Director |
| Hao Shi | Director, Executive |
| Justin Smithline | Director |
| Paul Theunissen | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1 Deer Park Drive Suite G 5
Monmouth Junction, NJ, 08852
Monmouth Junction, NJ, 08852